Anthera – $15 Million Shelf-Takedown Offering

San Francisco – March 22, 2017 – Cooley advised the underwriter on Anthera’s $15 million shelf-takedown offering of 30,000,000 shares of common stock and two tranches of warrants to purchase up to an aggregate of 60,000,000 shares. The underwriter has a 30-day option to purchase up to an additional 4,500,000 shares of common stock and/or warrants to purchase up to an additional 9,000,000 shares of common stock at the public offering prices.

Rodman & Renshaw, a unit of HC Wainwright & Co., acted as the sole book-running manager for the offering.

Anthera, which trades on The NASDAQ Global Market as “ANTH,” is a clinical-stage biopharmaceutical company focused on developing and commercializing products to treat serious and life-threatening diseases, including exocrine pancreatic insufficiency and IgA nephropathy.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Related Contacts
Drew Williamson Partner, San Francisco
Charlie Kim Partner, San Diego
David Peinsipp Partner, San Francisco
Kristin VanderPas Partner, San Francisco
Denny Won Associate, San Diego
Phillip McGill Associate, San Diego
Natasha Leskovsek Partner, Washington, DC
Phil Mitchell Partner, New York
Bill Christiansen Partner, Seattle
Jordan Phelan Patent Agent, Washington, DC
Susan Cooper Philpot Partner, San Francisco